Kuanping Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage
Geographical Focus
China
Industries Focus
- Technology
- Healthcare
- Consumer Goods
- Biotech
Investor Details Founded: 2016
Kuanping Capital is a Shanghai-based private equity firm specializing in healthcare-focused investments across China. The firm concentrates on sectors such as biotech, healthcare, consumer goods, and technology, aiming to support innovative companies in these industries.
Established in 2016, Kuanping Capital employs a research-based, strategy-oriented approach to active investments. The firm partners with outstanding entrepreneurs to achieve superior returns through value creation, focusing on early-stage, growth, and late-stage investments.
Kuanping Capital has demonstrated its commitment to the healthcare sector by leading significant funding rounds, such as the over $20 million Series B+ financing for Brattea, a leading renal denervation company in China. This investment underscores the firm's dedication to advancing medical technologies and improving patient outcomes.
Requirements
- Focus on healthcare, biotech, consumer goods, and technology sectors
- Preference for early-stage to late-stage companies with innovative solutions
- Alignment with Kuanping Capital's strategic investment approach
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Brattea
Claim this Investor
Are you an official representative of Kuanping Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim